源耀生物 (873737.OC)

+ 收藏

现金流量表(源耀生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市前
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 334,866,176.96948,407,999.10452,684,676.98793,562,517.79291,477,251.22
 收到的税费返还(元) 113,007.452,612,202.2552,027.62186,167.38285,830.87
 收到其他与经营活动有关的现金(元) 332,243.282,451,870.672,365,639.272,727,517.693,198,170.35
 经营活动现金流入小计(元) 335,311,427.69953,472,072.02455,102,343.87796,476,202.86294,961,252.44
 购买商品、接受劳务支付的现金(元) 301,843,875.81876,222,907.14404,626,929.94734,864,002.78276,800,825.55
 支付给职工以及为职工支付的现金(元) 21,224,332.7142,397,614.3123,100,920.7538,699,547.4220,429,839.36
 支付的各项税费(元) 1,214,534.553,953,177.952,945,759.293,194,942.041,828,482.01
 支付其他与经营活动有关的现金(元) 3,650,381.127,499,829.992,876,647.776,739,361.753,799,849.05
 经营活动现金流出小计(元) 327,933,124.19930,073,529.39433,550,257.75783,497,853.99302,858,995.97
 经营活动产生的现金流量净额(元) 7,378,303.5023,398,542.6321,552,086.1212,978,348.87-7,897,743.53
二、投资活动产生的现金流量
 收回投资收到的现金(元) 13,129,470.8082,549,845.8512,193,136.4811,303,173.691,442,832.70
 取得投资收益收到的现金(元) 192,552.83-147,510.83-194,792.34
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) -179,546.00---
 投资活动现金流入小计(元) 13,322,023.6382,729,391.8512,340,647.3111,303,173.691,637,625.04
 购建固定资产、无形资产和其他长期资产支付的现金(元) 3,962,415.4418,610,803.817,029,494.307,165,066.644,202,460.03
 投资支付的现金(元) 7,900,219.6072,890,640.207,307,117.0013,286,345.99689,170.00
 投资活动现金流出小计(元) 11,862,635.0491,501,444.0114,336,611.3020,451,412.634,891,630.03
 投资活动产生的现金流量净额(元) 1,459,388.59-8,772,052.16-1,995,963.99-9,148,238.94-3,254,004.99
三、筹资活动产生的现金流量
 吸收投资收到的现金(元) ---1,400,000.001,400,000.00
 取得借款收到的现金(元) 9,500,000.0060,000,000.0020,000,000.0041,300,000.007,800,000.00
 筹资活动现金流入小计(元) 9,500,000.0060,000,000.0020,000,000.0042,700,000.009,200,000.00
 偿还债务支付的现金(元) 16,000,000.0068,500,000.0037,500,000.0032,800,000.0010,800,000.00
 分配股利、利润或偿付利息支付的现金(元) 328,608.341,110,268.07493,999.991,200,315.58549,835.01
 支付其他与筹资活动有关的现金(元) 2,168,675.001,429,153.001,429,153.001,299,872.58-
 筹资活动现金流出小计(元) 18,497,283.3471,039,421.0739,423,152.9935,300,188.1611,349,835.01
 筹资活动产生的现金流量净额(元) -8,997,283.34-11,039,421.07-19,423,152.997,399,811.84-2,149,835.01
四、汇率变动对现金及现金等价物的影响(元) 221,393.77165,134.3121,123.09-6,635.98-31,907.84
五、现金及现金等价物净增加额(元) 61,802.523,752,203.71154,092.2311,223,285.79-13,333,491.37
 加:期初现金及现金等价物余额(元) 31,821,023.1228,548,589.4128,548,589.4117,325,303.6217,325,303.62
 期末现金及现金等价物余额(元) 31,882,825.6432,300,793.1228,702,681.6428,548,589.413,991,812.25
补充资料:
 净利润(元) -12,064,639.795,038,032.20-2,442,415.443,688,070.16-3,891,465.35
 固定资产和投资性房地产折旧(元) 6,504,074.7215,707,676.175,328,081.7113,872,425.076,888,881.36
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 6,504,074.7215,707,676.175,328,081.7113,872,425.076,888,881.36
 无形资产摊销(元) 257,502.30535,123.94241,881.73444,862.36218,443.80
 处置固定资产、无形资产和其他长期资产的损失(元) --568,601.19--
 固定资产报废损失(元) -5,984.68567,080.09-119,683.81-
 公允价值变动损失(元) 1,790,997.22-483,570.32-309,430.00517,030.00543,030.00
 财务费用(元) 371,716.551,090,596.62568,517.821,395,569.77624,879.13
 投资损失(元) -5,151,597.90-11,536,053.55-5,557,719.893,199,877.10-420,991.50
 递延所得税(元) -6,031,009.83-4,426,750.60-556,635.09822,668.88-1,934,731.00
  其中:递延所得税资产减少(元) -3,479,954.54-4,426,750.60-633,992.59951,926.38-1,805,473.50
 递延所得税负债增加(元) -2,551,055.29-77,357.50-129,257.50-129,257.50
 存货的减少(元) 9,320,924.063,239,273.2310,002,488.11-3,748,123.26-39,354.97
 经营性应收项目的减少(元) 2,898,622.0412,684,091.3222,041,764.36-31,906,765.95-14,954,696.76
 经营性应付项目的增加(元) 6,558,734.72-784,955.00-12,829,187.6914,216,214.983,093,505.17
 其他(元) 2,051,044.333,210,122.102,523,915.005,233,702.502,400,000.00
 现金的期末余额(元) 31,882,825.64-28,702,681.6428,548,589.413,991,812.25
 减:现金的期初余额(元) 32,300,793.1228,548,589.4128,548,589.4117,325,303.6217,325,303.62
 加:现金等价物的期末余额(元) -32,300,793.12---
 现金及现金等价物的净增加额(元) -417,967.483,752,203.71154,092.2311,223,285.79-13,333,491.37
公告日期 2024-08-272024-04-292023-08-292023-04-272022-08-25
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院